Deere & Company
DEDeere & Company's price has outrun its earnings. +42.6% in a year against EPS −27.8% — the market is paying now for delivery later.
The sharpest disagreement: the price moved +42.6% in a year while annual EPS moved −27.8% — the difference is re-rating, and re-rating has to be repaid with earnings.
The price is in a confirmed uptrend (37 weeks in) while the P/E sits at the 100th percentile of its own 4-year range. Underneath, the last four quarters read improving — profit +7.0% year on year, and 113% of the last 3 years' profit arrived as cash. What settles it: whether earnings grow into a price that has already moved.
Price story Before the numbers, the tape. A stock price moves through four repeating seasons: a flat base (stage 1), an advance (2), a top (3), a decline (4). Where the price sits in that cycle frames everything below.
Deere & Company trades at $669, in a confirmed uptrend and 37 weeks into that stage. That is +16.4% against its own 200-day average. It sits at 90% of a 52-week range of $446 to $694. On relative strength it has been ahead of the S&P 500 on a trailing-13-week view for 7 straight weeks.
Today the stock is in a confirmed uptrend — week 37 of stage 2. At $669 it trades +16.4% versus its 200-day average and sits at 90% of its 52-week range ($446–$694).
Against the market, two honest reads. Cumulative: over the last 10.2 years the stock moved +727% while the S&P 500 moved +255% — ahead of the index over the full window. Recent form: on a trailing-13-week view the stock has been ahead for 7 straight weeks — the ribbon below is that same metric, week by week.
What would end the trend, mechanically: two Friday closes in a row below the 200-day line. That is the exit rule — no debates.
Valuation P/E is the price of $1 of annual profit: how many dollars the market pays for each dollar the company earns in a year.
Deere & Company trades at 38.0× P/E, about the priciest it has ever traded. Its long-run median P/E is 17.6×, measured across 4.4 years of weekly readings. This places the multiple against the stock’s own record, and says nothing about what the business is worth.
Today's P/E of 38.0× is about the priciest it has ever traded, against a long-run median of 17.6× measured over 4.4 years of weekly readings. This is a comparison against the stock's own history — not a claim about what it is worth.
🚨 Why the multiple sits where it does: over the past year annual EPS moved −27.8% against a +42.6% price move — the price outran earnings, pushing the multiple UP its own range.
The price move, decomposed: over 3y, of the +17.6%/yr price move, ~−19.0%/yr came from earnings growth and ~+36.6 pp from the multiple (expanding). The split is the honest approximate (price return minus earnings growth); it makes the rally itself visible instead of hiding it behind the percentile.
Put together: the multiple is full against its own past, so the story rests on the earnings line underneath it, not the multiple.
Stage: Turning around Every business sits somewhere on a fundamental arc, and this page names the spot before anything else. The last twelve quarters of revenue, profit and EPS growth — plus the return the business earns on its capital — are read as curves: Deteriorating (the curves are falling), Turning around (a trough has just formed and the last few quarters lift off it), Improving (the climb off the trough is sustained), Consistent (steadily positive with healthy returns), Topping out (still high but decelerating from the peak). When the curves genuinely disagree the read is Mixed; too little history is No read. CAGR (compound annual growth rate) is the smooth yearly pace that turns the starting value into the latest one — the fairest way to compare growth across different time spans. Read the columns together: if the 1-year number towers over the 10-year, recent growth is running hotter than the long-run trend. A dash means that window is not held, or the base year was a loss (where a growth rate is not meaningful).
Deere & Company reads as turning around on its fundamental arc. Turning around — profit growth swung from −37.6% at the trough to −6.5%, a 5-quarter improving streak, ROCE holding at 9.0%. The read is built from 12 quarters across 4 curves, on full evidence.
Why it matters: growth inflections are where re-ratings start — the curves say a turn is forming, so the question becomes whether the next quarters confirm it.
| 1yr | 3yr | 5yr | 10yr | |
|---|---|---|---|---|
| Revenue | −11.4% | −4.6% | — | — |
| Profit | −29.2% | −11.0% | — | — |
| EPS | −27.8% | −7.4% | — | — |
| Stock price | +42.6% | +17.6% | +13.9% | +23.4% |
4-Factor Sector Score
66.4/100 — rank 1 of 21 in Farm & Heavy Construction Machinery · 85% evidence confidence
Deere & Company scores 66.4 out of 100 against the 21 companies it is compared with in Farm & Heavy Construction Machinery, ranking 1. Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
The four contributions add to the total exactly: 19.8 + 15.9 + 12.5 + 18.2 = 66.4. This is the SAME number shown on the sector comparison — it is computed once, for the whole peer set, and read here.
What would change it: The read weakens if profit growth turns negative or margin improvement reverses while sector-relative strength deteriorates.
Revenue Revenue is the top line: everything the company billed its customers in the period.
Deere & Company reported $12.6 B of revenue in the Aug 26 quarter, +4.9% year on year. That is the 4th straight quarter of year-on-year growth. Over 4 years it has compounded at 0.9% a year. The last full year, FY25, came in at $45.6 B. The last four reported quarters add to $47.9 B.
FY25 revenue came in at $45.6 B (−11.4% on the year), capping 4 years at 0.9% compound. The latest quarter (Aug 26) printed $12.6 B, +4.9% year on year — the 4th consecutive quarter of year-over-year growth.
Pace check: the last four quarters averaged +8.8% growth against the decade's 0.9% — the current year is running faster than its own long-run rate.
Acceleration check: trailing-twelve-month revenue grew +8.3% over the last 4 quarters against −7.4%/yr over the last 8 — accelerating; TTM profit −6.5% vs −23.0%/yr — accelerating.
Operating margin Operating margin is what is left of every $100 of sales after running the business, before interest and tax. It is the cleanest read on pricing power and cost control.
Deere & Company's operating margin is 13.4% in the Aug 26 quarter, −1.7 percentage points against the same quarter a year ago. Across 5 fiscal years the operating margin has ranged 14.5% to 21.9%. The current quarter is running below every full year in that window.
The latest quarter's operating margin is 13.4%, −1.7 pp against the same quarter a year ago. Across 5 fiscal years the operating margin has ranged 14.5%–21.9%.
🚨 Why the margin moved: operating margin went −1.7 pp year on year while gross margin went −0.2 pp — the loss came mostly below the gross line: operating leverage, with costs spread over a bigger revenue base.
Net profit Net profit is what survives every cost, interest and tax — the number EPS, dividends and book value all grow from.
Deere & Company earned $1.4 B of net profit in the Aug 26 quarter, +7.0% year on year. Full-year FY25 profit was $5.0 B. The 4-year compound rate is −4.2%. That is 10.9% of the quarter's revenue. The same quarter a year earlier earned $1.3 B.
Aug 26 profit was $1.4 B, +7.0% year on year. On the full year, FY25 printed $5.0 B (−29.2%), and the 4-year compound rate is −4.2%.
Why profit moved: revenue contributed +4.9% and the margin −1.7 pp — the quarter was revenue-led, with the margin roughly flat.
Pace comparison, last four quarters: profit −8.5% vs revenue +8.8%. Profit is growing slower than sales — costs are eating the growth before it reaches the bottom line.
Cash flow — the router The P&L says what was earned; the cash-flow statement says what actually arrived. Operating cash flow (CFO) against profit is the cleanest lie detector in the accounts.
Over the last 3 fiscal years 113% of Deere & Company's reported profit arrived as operating cash — the cash follows the profit. In FY25 that was $7.5 B of operating cash against $5.0 B of profit. After $4.2 B of capital spending, $3.2 B was left as free cash.
FY25: operating cash of $7.5 B against reported profit of $5.0 B, leaving free cash of $3.2 B after $4.2 B of capital spending. Across the last 3 fiscal years the conversion rate is 113% of profit.
Cash-flow readings here are annual — that is the resolution our series carries, so this section moves once a year.
Why: conversion is measured cleanly, but the working-capital day-counts behind it sit below what we hold — the move is shown without inventing its driver.
Router verdict: the visible cash user is investment — the next section checks what the spending is buying.
Where the cash goes Working capital is the cash tied up between paying suppliers and getting paid: debtor days (customers owe), inventory days (stock waits), and the cash conversion cycle (the whole loop, in days of sales).
Deere & Company does not report the debtor, inventory and payable day-counts a cash cycle is built from, so this section reads the investment side instead. Capital spending ran $14.0 B over the last 3 years. Averaged over those years that is 10.2% of FY25 revenue a year.
Working-capital day-counts are not in our numbers for this stock, so this section reads the investment side — where the cash is being put to work.
On the investment side: capital spending of $14.0 B over the last 3 fiscal years.
The synthesis: the cash is going into capacity, not disappearing into the cycle — the question becomes whether the new capacity earns.
Return on equity Return on equity (ROE) is the profit the business earns on its shareholders’ money. With the full capital-employed split not in our numbers, ROE is the cleanest long ladder we can draw here.
Deere & Company earns a ROE of 19% in FY25. Return on invested capital clears the cost of that capital by −1.2 percentage points, so growth here is not yet paying for the capital it uses. The wiring behind it is 11.0% net margin on 0.43× asset turns.
FY25 ROE is 19%.
🚨 Why the return is what it is — the wiring (FY25): 11.0% net margin × 0.43× asset turns × 4.08× balance-sheet leverage ≈ 19.3% on equity. Margin does its share; leverage is a meaningful part of the equation.
The capstone test — ROIC − WACC: 5.7% − 6.9% = a −1.2 pp spread. The 6.9% is an estimate of this company's own cost of capital — read the sign and the size of the spread, not the decimals. Negative — growth at these returns destroys value until the returns recover.
Dividend A dividend is cash paid out per share. Dividend per share is the declared amount for the period; the trailing twelve-month total is the four most recent quarters added together.
Deere & Company paid $6.48 per share over the last four reported quarters. The most recent declaration was $1.62 for Aug 26. Against the current price of $669 that is a trailing yield of 0.97%, measured on dividends already paid rather than on a forecast.
Deere & Company paid $6.48 per share across the last four reported quarters, most recently $1.62 for Aug 26. Against the current price of $669 the trailing twelve months work out to 0.97% — trailing dividends measured against today's price, not a forward estimate.
Debt Debt-to-equity says how much of the business is funded by borrowings. Low is the safe corner; the trend matters as much as the level.
Deere & Company carries total debt of $64.6 B against shareholder equity of $28.0 B as of Aug 26, a debt-to-equity of 2.30. On the annual view that ratio went from 2.65 in FY21 to 2.48 in FY25. Read the returns elsewhere on this page with that leverage in mind.
Aug 26: total debt of $64.6 B against shareholder equity of $28.0 B — a debt-to-equity of 2.30. On the annual view, debt-to-equity went from 2.65 (FY21) to 2.48 (FY25). Read the returns on this page with that leverage in mind.
Ownership There is no quarter-by-quarter holder register to read here, so we read the crowd through short interest — the slice of tradable shares currently sold short, positioned for a fall.
1.9% of Deere & Company's tradable float is currently sold short — the crowd is not positioned against this stock. At typical trading volumes those positions would take about 4.5 days to buy back. There is no quarter-by-quarter holder register to read for this filer, so the crowd is read through short interest instead.
The latest reading: 1.9% of the float is sold short, and at typical trading volumes it would take about 4.5 days to buy those positions back. The crowd is not positioned against this stock. This is a single point-in-time reading — we do not yet hold its history, so we show no trend chart.
Why it sits there: who is doing the shorting, and why, does not travel with the number — the level is shown without inventing its story.
Safety line The Z-score estimates how far a company sits from balance-sheet distress — above roughly 3 is safe, below roughly 1.8 is the danger zone. It was built for manufacturers, so it is not applied to banks and lenders.
Deere & Company: the Z-score reads 3.00. A Z-score above roughly 3 reads as safe and below roughly 1.8 as the distress zone, so this sits well clear of distress. It is a distance-to-distress estimate from the balance sheet, not a forecast of failure.
Why it matters: a Z-score of 3.00 sits well clear of the distress zone — the balance sheet is not the risk here.
The safety line in one sentence: the Z-score reads 3.00.
| Company | Score | Price stage | Growth & earnings/35 | Capital efficiency/25 | Valuation/20 | Relative strength/20 |
|---|---|---|---|---|---|---|
| 1Deere & Companythis pageDE | 66.4/100Favorable setup85% evidence | BREAKING OUT | 19.8/35 Revenue 8.3% · PAT -6.4% · OPM change -1.7 pp 95% evidence | 15.9/25 ROCE 9.1% · OPM 13.4% 76% evidence | 12.5/20 P/E 32.8× · PEG 1 65% evidence | 18.2/20 RS sector 13.8% · RS bench 13.1% · 1Y 42.6%6 of 12 weeks ahead 100% evidence |
| Exact sum: 19.8 + 15.9 + 12.5 + 18.2 = 66.4 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 2Caterpillar Inc.CAT | 63.6/100Mixed-positive evidence81% evidence | ASLEEP | 27.5/35 Revenue 18.4% · PAT 14.9% · OPM change 4.5 pp 83% evidence | 21.2/25 ROCE 22.2% · OPM 22.2% 76% evidence | 5.4/20 P/E 45.2× · PEG 2.48 65% evidence | 9.5/20 RS sector 0.8% · RS bench 0.5% · 1Y 67.8%3 of 12 weeks ahead 100% evidence |
| Exact sum: 27.5 + 21.2 + 5.4 + 9.5 = 63.6 · Decision use: Strong business, demanding price: keep it on the quality list, but require either earnings upgrades or valuation compression. | ||||||
| 3CNH Industrial N.V.CNH | 58.9/100Mixed-positive evidence66% evidence | BREAKING OUT | 14.4/35 Revenue -4% · PAT -62.5% · OPM change -3.8 pp 53% evidence | 10.8/25 ROCE 1% · OPM 9.9% 57% evidence | 14.2/20 P/E 35.5× · PEG 0.46 65% evidence | 19.5/20 RS sector 17.7% · RS bench 16.8% · 1Y 23.2%6 of 12 weeks ahead 100% evidence |
| Exact sum: 14.4 + 10.8 + 14.2 + 19.5 = 58.9 · Decision use: Price leads the evidence: RS versus the benchmark is 16.8%, but earnings trajectory is weak. Wait for revenue and profit confirmation. | ||||||
| 4The Manitowoc Company, Inc.MTW | 56.3/100Thin evidence · provisional55% evidence | BREAKING OUT | 17.5/35 Revenue 5.2% · PAT -82.6% · OPM change -0.5 pp 40% evidence | 7.8/25 ROCE 0.2% · OPM 0.6% 57% evidence | 14.0/20 P/E 58.3× · PEG 0.14 65% evidence | 17.0/20 RS sector 46.3% · RS bench 45.2% · 1Y 109.2%7 of 12 weeks ahead 70% evidence |
| Exact sum: 17.5 + 7.8 + 14 + 17 = 56.3 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 5Blue Bird CorporationBLBD | 54.9/100Mixed-positive evidence66% evidence | ASLEEP | 19.3/35 Revenue 10.1% · PAT 21.1% · OPM change 1.7 pp 53% evidence | 13.6/25 ROCE 10.4% · OPM 11.1% 57% evidence | 15.3/20 P/E 13.5× · PEG 0.52 65% evidence | 6.7/20 RS sector -3.8% · RS bench -4.1% · 1Y 3.3%5 of 12 weeks ahead 100% evidence |
| Exact sum: 19.3 + 13.6 + 15.3 + 6.7 = 54.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 6Federal Signal CorporationFSS | 53.2/100Thin evidence · provisional56% evidence | ASLEEP | 21.3/35 Revenue — · PAT — · OPM change 1.7 pp 39% evidence | 15.6/25 ROCE 6.3% · OPM 15.9% 76% evidence | 9.9/20 P/E 27.7× · PEG — 15% evidence | 6.4/20 RS sector -6.1% · RS bench -6.6% · 1Y -7.9%5 of 12 weeks ahead 100% evidence |
| Exact sum: 21.3 + 15.6 + 9.9 + 6.4 = 53.2 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 7AGCO CorporationAGCO | 52.9/100Thin evidence · provisional56% evidence | TURNING | 19.6/35 Revenue — · PAT — · OPM change 1 pp 39% evidence | 9.7/25 ROCE 1.7% · OPM 3.4% 76% evidence | 11.0/20 P/E 16.6× · PEG — 15% evidence | 12.6/20 RS sector -1% · RS bench -1.7% · 1Y 9.3%1 of 12 weeks ahead 100% evidence |
| Exact sum: 19.6 + 9.7 + 11 + 12.6 = 52.9 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 8Gencor Industries, Inc.GENC | 51.5/100Thin evidence · provisional60% evidence | BREAKING OUT | 13.3/35 Revenue -10.3% · PAT -7.1% · OPM change -4.5 pp 53% evidence | 11.5/25 ROCE 2% · OPM 12.5% 57% evidence | 11.6/20 P/E 17× · PEG 1.32 65% evidence | 15.1/20 RS sector 8.7% · RS bench 8.1% · 1Y 13%6 of 12 weeks ahead 70% evidence |
| Exact sum: 13.3 + 11.5 + 11.6 + 15.1 = 51.5 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 9Oshkosh CorporationOSK | 48.7/100Thin evidence · provisional56% evidence | FADING | 16.2/35 Revenue — · PAT — · OPM change -4.1 pp 39% evidence | 13.2/25 ROCE 3.4% · OPM 3.5% 76% evidence | 10.6/20 P/E 17.6× · PEG — 15% evidence | 8.7/20 RS sector -4.2% · RS bench -5% · 1Y 8.8%5 of 12 weeks ahead 100% evidence |
| Exact sum: 16.2 + 13.2 + 10.6 + 8.7 = 48.7 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 10Alamo Group Inc.ALG | 48.2/100Mixed-negative evidence66% evidence | FADING | 16.6/35 Revenue 2.3% · PAT -12.2% · OPM change -1.3 pp 53% evidence | 13.3/25 ROCE 3% · OPM 10.1% 57% evidence | 10.8/20 P/E 19.7× · PEG 1.36 65% evidence | 7.5/20 RS sector -8.5% · RS bench -9.2% · 1Y -15.1%5 of 12 weeks ahead 100% evidence |
| Exact sum: 16.6 + 13.3 + 10.8 + 7.5 = 48.2 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 11PACCAR IncPCAR | 45.6/100Mixed-negative evidence81% evidence | FADING | 16.2/35 Revenue -10.6% · PAT -18.5% · OPM change 0.5 pp 83% evidence | 13.2/25 ROCE 2.7% · OPM 11.7% 76% evidence | 9.6/20 P/E 25.2× · PEG 1.48 65% evidence | 6.6/20 RS sector -4.2% · RS bench -4.8% · 1Y 18.9%5 of 12 weeks ahead 100% evidence |
| Exact sum: 16.2 + 13.2 + 9.6 + 6.6 = 45.6 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 12Astec Industries, Inc.ASTE | 41.1/100Thin evidence · provisional60% evidence | ASLEEP | 18.1/35 Revenue 11.5% · PAT 73.3% · OPM change -3.9 pp 53% evidence | 8.1/25 ROCE 1% · OPM 2.3% 57% evidence | 11.4/20 P/E 48.1× · PEG 1.01 65% evidence | 3.5/20 RS sector -23.7% · RS bench -24.2% · 1Y -14.4%0 of 12 weeks ahead 70% evidence |
| Exact sum: 18.1 + 8.1 + 11.4 + 3.5 = 41.1 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 13Terex CorporationTEX | 40.5/100Thin evidence · provisional56% evidence | ASLEEP | 15.6/35 Revenue — · PAT — · OPM change -10.3 pp 39% evidence | 10.8/25 ROCE 2.8% · OPM -4.7% 76% evidence | 9.4/20 P/E 36.9× · PEG — 15% evidence | 4.7/20 RS sector -6.4% · RS bench -7.1% · 1Y 13.2%4 of 12 weeks ahead 100% evidence |
| Exact sum: 15.6 + 10.8 + 9.4 + 4.7 = 40.5 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 14Lindsay CorporationLNN | 39.5/100Mixed-negative evidence75% evidence | ASLEEP | 12.5/35 Revenue -7.1% · PAT -27.3% · OPM change -2.5 pp 83% evidence | 13.0/25 ROCE 2.7% · OPM 11.5% 76% evidence | 7.7/20 P/E 21× · PEG 2.04 65% evidence | 6.3/20 RS sector -6.7% · RS bench -7.3% · 1Y -14.9%1 of 12 weeks ahead 70% evidence |
| Exact sum: 12.5 + 13 + 7.7 + 6.3 = 39.5 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 15SunScout Holding LimitedSNSC | 55.7/100Thin evidence · provisional11% evidence | 17.5/35 Revenue — · PAT — · OPM change — 0% evidence | 18.2/25 ROCE 30.5% · OPM — 46% evidence | 10.0/20 P/E — · PEG — 0% evidence | 10.0/20 RS sector — · RS bench — · 1Y — 0% evidence | |
| Exact sum: 17.5 + 18.2 + 10 + 10 = 55.7 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 16Wabash National CorporationWNC | 44.0/100Thin evidence · provisional50% evidence | FADING | 12.1/35 Revenue — · PAT — · OPM change -99.9 pp 39% evidence | 5.0/25 ROCE -2.7% · OPM -17.3% 76% evidence | 11.3/20 P/E 1.7× · PEG — 15% evidence | 15.6/20 RS sector 11.6% · RS bench 10.5% · 1Y 8.7%11 of 12 weeks ahead 70% evidence |
| Exact sum: 12.1 + 5 + 11.3 + 15.6 = 44 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 17Aebi Schmidt Holding AGAEBI | 38.9/100Thin evidence · provisional50% evidence | ASLEEP | 15.6/35 Revenue 61.2% · PAT -60.9% · OPM change -2.4 pp 53% evidence | 10.1/25 ROCE 1.3% · OPM 3.4% 57% evidence | 8.8/20 P/E 80.9× · PEG — 15% evidence | 4.4/20 RS sector -9.5% · RS bench -10.2% · 1Y -4.1%5 of 12 weeks ahead 70% evidence |
| Exact sum: 15.6 + 10.1 + 8.8 + 4.4 = 38.9 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 18Titan International, Inc.TWI | 38.4/100Thin evidence · provisional50% evidence | ASLEEP | 16.7/35 Revenue — · PAT — · OPM change -5.1 pp 39% evidence | 6.8/25 ROCE 1.1% · OPM -2.7% 76% evidence | 10.9/20 P/E 16.8× · PEG — 15% evidence | 4.0/20 RS sector -16.4% · RS bench -17.2% · 1Y -13.1%1 of 12 weeks ahead 70% evidence |
| Exact sum: 16.7 + 6.8 + 10.9 + 4 = 38.4 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 19Columbus McKinnon CorporationCMCO | 34.5/100Thin evidence · provisional50% evidence | BREAKING OUT | 14.1/35 Revenue — · PAT — · OPM change -37 pp 39% evidence | 6.0/25 ROCE -0.6% · OPM -35% 76% evidence | 8.7/20 P/E 82.1× · PEG — 15% evidence | 5.7/20 RS sector -8.3% · RS bench -9.1% · 1Y 7%8 of 12 weeks ahead 70% evidence |
| Exact sum: 14.1 + 6 + 8.7 + 5.7 = 34.5 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 20Hyster-Yale, Inc.HY | 29.3/100Thin evidence · provisional50% evidence | ASLEEP | 8.9/35 Revenue -12.2% · PAT -175.7% · OPM change -5.8 pp 53% evidence | 6.3/25 ROCE -2.8% · OPM -3.5% 57% evidence | 8.5/20 P/E 263.3× · PEG — 15% evidence | 5.6/20 RS sector -8.5% · RS bench -9% · 1Y -8.4%0 of 12 weeks ahead 70% evidence |
| Exact sum: 8.9 + 6.3 + 8.5 + 5.6 = 29.3 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 21CEA Industries Inc.BNC | 28.2/100Thin evidence · provisional50% evidence | 10.7/35 Revenue — · PAT — · OPM change -2254.1 pp 39% evidence | 3.0/25 ROCE -43.5% · OPM -992.9% 76% evidence | 11.5/20 P/E 1.2× · PEG — 15% evidence | 3.0/20 RS sector -63.7% · RS bench -65.3% · 1Y -85.3%0 of 6 weeks ahead to 2026-08-07 70% evidence | |
| Exact sum: 10.7 + 3 + 11.5 + 3 = 28.2 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
Missing observations are not scored as bad. Their missing weight lowers confidence and pulls the final score toward neutral. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led S&P 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step curve the sector itself is placed on — basing, turning, breaking out, leader, fading, asleep — read from how many weeks running it has led S&P 500 and whether that lead is widening or shrinking. It describes where the PRICE stands, not the earnings trajectory and not a recommendation, and it is left blank for a company whose weekly history is too short or too stale to read.
Frequently asked questions
What is Deere & Company's stock price today?
Deere & Company trades at $669, +42.6% over the past year. The company is valued at $181 B. The stock sits at 90% of its 52-week range of $446–$694, +16.4% versus its 200-day average. On the tape, the price is in a confirmed uptrend, 37 weeks in. — as of 17 September 2026.
What were Deere & Company's latest quarterly results?
Deere & Company reported revenue of $12.6 B and net profit of $1.4 B for the Aug 26 quarter. Revenue rose 4.9% and profit rose 7.0% year on year. Earnings per share were $5.10. The operating margin was 13.4%, 1.7 pp lower than a year earlier. — as of 17 September 2026.
What is Deere & Company's revenue?
Deere & Company reported revenue of $12.6 B in the Aug 26 quarter, +4.9% year on year. For the full FY25 fiscal year, revenue was $45.6 B (−11.4%). Over the last 4 years revenue compounded at 0.9% a year. — as of 17 September 2026.
What is Deere & Company's profit?
Deere & Company earned $1.4 B of net profit in the Aug 26 quarter, +7.0% year on year. Full-year FY25 profit was $5.0 B. The operating margin ran 13.4% in the latest quarter. — as of 17 September 2026.
What is Deere & Company's market cap?
Deere & Company's market capitalisation is $181 B at a stock price of $669. Market cap is the share price multiplied by shares outstanding, so it is restated whenever the price moves. — as of 17 September 2026.
What is Deere & Company's P/E ratio?
Deere & Company trades at a P/E of 38.0×, at the most expensive it has been in 4 years, against a long-run median of 17.6×. This is a comparison with the stock's own history, not a value call — as of 17 September 2026.
Does Deere & Company pay a dividend?
Yes — Deere & Company declared $1.62 per share for Aug 26, and $6.48 per share across the last four reported quarters. — as of 17 September 2026.
What is Deere & Company's dividend per share?
Deere & Company's most recently declared dividend is $1.62 per share for Aug 26, giving $6.48 per share over the trailing twelve months. Each figure is the amount declared for that quarter as reported, added across four quarters for the trailing total. — as of 17 September 2026.
What is Deere & Company's dividend yield?
Deere & Company's trailing dividend yield is 0.97%: $6.48 declared per share across the last four reported quarters, against a share price of $669. Each quarter’s figure is the amount declared for that quarter as reported, added across four quarters and divided by the latest close. — as of 17 September 2026.
Is Deere & Company overvalued?
On its own history, Deere & Company looks expensive: its P/E of 38.0× sits at the most expensive it has been in 4 years (long-run median 17.6×). That is a percentile read against the stock's own past, not a price opinion or a direction call. — as of 17 September 2026.
Is Deere & Company growing?
Yes — Deere & Company is growing: latest-quarter revenue +4.9% year on year, profit +7.0%, and the margin −1.7 pp at 13.4%. The 4-year compound rates are 0.9% (revenue) and −4.2% (profit). The earnings engine currently reads: improving — as of 17 September 2026.
How is Deere & Company performing?
Deere & Company is in a confirmed uptrend, 37 weeks in. Its latest quarter's revenue rose 4.9% and profit rose 7.0% year on year. Against the S&P 500 it has been ahead on a trailing-13-week view for 7 weeks. This describes what the data did, not a rating. — as of 17 September 2026.
What stage is Deere & Company in?
Turning around — profit growth swung from −37.6% at the trough to −6.5%, a 5-quarter improving streak, ROCE holding at 9.0%. The read comes from the last 12 quarters of growth (revenue growth +8.3% latest, profit growth −6.5% latest, eps growth −5.9% latest) plus the ROCE curve, classified by deterministic rules — a trajectory read, not a buy or sell call — as of 17 September 2026.
Is Deere & Company in an uptrend?
Yes — the price is in a confirmed uptrend (week 37 of stage 2), trading +16.4% versus its 200-day average and at 90% of its 52-week range. Price stages cycle base → advance → top → decline, and the stage names where this stock sits in that cycle — as of 17 September 2026.
Is Deere & Company beating the market?
On recent form, yes — Deere & Company has been ahead of the S&P 500 on a trailing-13-week view for 7 straight weeks, the same metric the week-by-week ribbon on this page draws. Separately, on the cumulative view: over the last 10.2 years the stock moved +727% against the S&P 500's +255% — ahead of the index over the full window. — as of 17 September 2026.
Will Deere & Company's stock price go up?
This page publishes no price forecast for Deere & Company. What it measures instead: the stock price is $669, the price is in a confirmed uptrend 37 weeks in. Its P/E of 38.0× sits at the 100th percentile of its own 4-year range. — as of 17 September 2026.
Is the market betting against Deere & Company?
No — short interest is 1.9% of Deere & Company's tradable float, about 4.5 days to cover at typical volumes. That is a low reading: the crowd is not positioned against this stock. With no quarter-by-quarter holder register here, short interest is the cleanest crowd read we hold — as of 17 September 2026.
Does Deere & Company have too much debt?
It carries real leverage — Deere & Company's debt-to-equity is 2.30. A year-by-year borrowings ladder is not in our numbers for this stock, so the latest reading is the cleanest hold. Read the returns on this page with that leverage in mind — as of 17 September 2026.
What is Deere & Company's capex?
Deere & Company spent $14.0 B on capital expenditure over the last 3 fiscal years, a figure derived from the change in fixed assets plus depreciation. In FY25 alone that was $4.2 B. — as of 17 September 2026.
What is Deere & Company's cash flow?
Deere & Company generated $7.5 B of operating cash flow in FY25 and $3.2 B of free cash flow after $4.2 B of capital spending. Reported profit that year was $5.0 B, so operating cash ran ahead of profit. — as of 17 September 2026.
Is Deere & Company's profit real cash?
Yes — over the last 3 fiscal years, 113% of Deere & Company's reported profit arrived as operating cash. In FY25, operating cash was $7.5 B against reported profit of $5.0 B. The cash then goes mostly into building capacity. Cash-flow resolution is annual — as of 17 September 2026.
How financially safe is Deere & Company?
On the balance sheet, the Z-score reads 3.00 — above roughly 3 is safe, below roughly 1.8 is the distress zone. That sits well clear of trouble. — as of 17 September 2026.
Where is Deere & Company in its business cycle?
Deere & Company's FY25 operating margin was 14.5%, against a 5-year band of 14.5%–21.9%: the low end of its own band, which is where recoveries start when they come. The latest quarter ran 13.4%. Profitability versus a company's own long band is the cleanest cycle clock this page holds — as of 17 September 2026.
What could break the Deere & Company story?
The sharpest disagreement: the price moved +42.6% in a year while annual EPS moved −27.8% — the difference is re-rating, and re-rating has to be repaid with earnings. Mechanically, two Friday closes in a row below the 200-day average would end the price trend — that is the exit rule this page tracks — as of 17 September 2026.
Is Deere & Company a stock worth studying right now?
This is not investment advice. The machine read: Deere & Company's price has outrun its earnings. +42.6% in a year against EPS −27.8% — the market is paying now for delivery later. The sharpest open question: whether earnings grow into a price that has already moved. Every number on this page is drawn deterministically from the raw series, with no forecasts and no price opinions — as of 17 September 2026.
Not SEBI Registered !! Not Investment advice !!